Canada Pension Plan Investment Board
SLNO

Canada Pension Plan Investment Board’s Soleno Therapeutics SLNO Stock Holding History

Canada Pension Plan Investment Board’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,300
Closed -$378K – 1849
2026
Q1 		$378K Buy
11,300
+1,800
+19% +$70.6K ﹤0.01% 1333
2025
Q4 		$440K Buy
+9,500
New +$521K ﹤0.01% 1348

Canada Pension Plan Investment Board's SLNO Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 11,300 shares — an estimated $378K sold.

Canada Pension Plan Investment Board first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $440K in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 11,300 Soleno Therapeutics shares in Q2 2026, an estimated $378K.
  • Canada Pension Plan Investment Board first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
  • Canada Pension Plan Investment Board's Soleno Therapeutics position peaked at $440K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.